
Sign up to save your podcasts
Or


This week, please join author Mathew S. Maurer as he discusses the article "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260126.13097
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week, please join author Mathew S. Maurer as he discusses the article "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260126.13097

134 Listeners

321 Listeners

504 Listeners

167 Listeners

906 Listeners

298 Listeners

3,374 Listeners

138 Listeners

1,150 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

437 Listeners

375 Listeners